106 related articles for article (PubMed ID: 2568146)
1. ICI 204448: a kappa-opioid agonist with limited access to the CNS.
Shaw JS; Carroll JA; Alcock P; Main BG
Br J Pharmacol; 1989 Apr; 96(4):986-92. PubMed ID: 2568146
[TBL] [Abstract][Full Text] [Related]
2. CI-977, a novel and selective agonist for the kappa-opioid receptor.
Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
[TBL] [Abstract][Full Text] [Related]
3. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
[TBL] [Abstract][Full Text] [Related]
4. PD117302: a selective agonist for the kappa-opioid receptor.
Clark CR; Birchmore B; Sharif NA; Hunter JC; Hill RG; Hughes J
Br J Pharmacol; 1988 Mar; 93(3):618-26. PubMed ID: 2836012
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of R-84760, a novel kappa-opioid receptor agonist.
Fujibayashi K; Sakamoto K; Watanabe M; Iizuka Y
Eur J Pharmacol; 1994 Aug; 261(1-2):133-40. PubMed ID: 8001635
[TBL] [Abstract][Full Text] [Related]
6. [3H]U-69593 a highly selective ligand for the opioid kappa receptor.
Lahti RA; Mickelson MM; McCall JM; Von Voigtlander PF
Eur J Pharmacol; 1985 Feb; 109(2):281-4. PubMed ID: 2986999
[TBL] [Abstract][Full Text] [Related]
7. [Comparative studies on the affinities of K-II and U-50488H for kappa opiate receptor].
Li JG; Ma SC; Lu SN; Wang CQ
Yao Xue Xue Bao; 1991; 26(1):10-4. PubMed ID: 1653514
[TBL] [Abstract][Full Text] [Related]
8. Effects of cations on binding, in membrane suspensions, of various opioids at mu-sites of rabbit cerebellum and kappa-sites of guinea-pig cerebellum.
Kosterlitz HW; Paterson SJ; Robson LE; Traynor JR
Br J Pharmacol; 1987 Jun; 91(2):431-7. PubMed ID: 3038237
[TBL] [Abstract][Full Text] [Related]
9. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
[TBL] [Abstract][Full Text] [Related]
10. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
[TBL] [Abstract][Full Text] [Related]
11. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
[TBL] [Abstract][Full Text] [Related]
12. P-7521--a new irreversible opioid ligand.
Jin WQ; Fan LQ; Chen XJ; Chi ZQ
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):205-10. PubMed ID: 2558497
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
14. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
15. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
16. [Characterization of 9 slowly dissociated opioid ligands azabicyclononances compounds to mu, delta, and kappa receptors].
Fan LQ; Jin WQ; Chi ZQ
Zhongguo Yao Li Xue Bao; 1991 May; 12(3):245-9. PubMed ID: 1664168
[TBL] [Abstract][Full Text] [Related]
17. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Su TP
J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
[TBL] [Abstract][Full Text] [Related]
18. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
Devlin T; Shoemaker WJ
J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
[TBL] [Abstract][Full Text] [Related]
19. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
Jin WQ; Chen XJ; Chi ZQ
Sci Sin B; 1987 Feb; 30(2):176-81. PubMed ID: 3039656
[TBL] [Abstract][Full Text] [Related]
20. Species differences in the stereoselectivity of kappa opioid binding sites for [3H]U-69593 and [3H]ethylketocyclazocine.
Benyhe S; Szücs M; Borsodi A; Wollemann M
Life Sci; 1992; 51(21):1647-55. PubMed ID: 1331638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
